Works matching IS 09198172 AND DT 2023 AND VI 30 AND IP 9

Results: 23

Issue Information.
Published in:
International Journal of Urology, 2023, v. 30, n. 9, p. 691, doi. 10.1111/iju.15295
Publication type:
Article
Congratulations to the 2021 Awardees!
Published in:
International Journal of Urology, 2023, v. 30, n. 9, p. 801, doi. 10.1111/iju.15284
Publication type:
Article
This Issue 30‐9.
Published in:
International Journal of Urology, 2023, v. 30, n. 9, p. 695, doi. 10.1111/iju.15275
By:
- Tsuchiya, Norihiko
Publication type:
Article
Editorial Comment to Clinical factors for tumor response, progression, and survival in nivolumab for advanced renal cell carcinoma in the SNiP‐RCC study.
Published in:
International Journal of Urology, 2023, v. 30, n. 9, p. 796, doi. 10.1111/iju.15269
By:
- Ishihara, Hiroki;
- Takagi, Toshio
Publication type:
Article
Clinical factors for tumor response, progression, and survival in nivolumab for advanced renal cell carcinoma in the SNiP‐RCC study.
Published in:
International Journal of Urology, 2023, v. 30, n. 9, p. 788, doi. 10.1111/iju.15265
By:
- Blas, Leandro;
- Shiota, Masaki;
- Miyake, Hideaki;
- Takahashi, Masayuki;
- Oya, Mototsugu;
- Tsuchiya, Norihiko;
- Masumori, Naoya;
- Matsuyama, Hideyasu;
- Obara, Wataru;
- Shinohara, Nobuo;
- Fujimoto, Kiyohide;
- Nozawa, Masahiro;
- Ohba, Kojiro;
- Ohyama, Chikara;
- Hashine, Katsuyoshi;
- Akamatsu, Shusuke;
- Kamba, Tomomi;
- Mita, Koji;
- Gotoh, Momokazu;
- Tatarano, Shuichi
Publication type:
Article
Editorial Comment to "The poor antitumor effect of pembrolizumab in advanced upper urothelial carcinoma with renal parenchymal invasion".
Published in:
International Journal of Urology, 2023, v. 30, n. 9, p. 786, doi. 10.1111/iju.15257
By:
- Kikuchi, Eiji;
- Hayakawa, Nozomi
Publication type:
Article
Editorial Comment to Efficacy and safety of pembrolizumab and axitinib as first‐line treatment for patients with advanced renal cell carcinoma: Real‐world experience in Japan.
Published in:
International Journal of Urology, 2023, v. 30, n. 9, p. 777, doi. 10.1111/iju.15256
By:
- Kondo, Tsunenori
Publication type:
Article
The poor antitumor effect of pembrolizumab in advanced upper urothelial carcinoma with renal parenchymal invasion.
Published in:
International Journal of Urology, 2023, v. 30, n. 9, p. 779, doi. 10.1111/iju.15231
By:
- Hara, Takuto;
- Furukawa, Junya;
- Okamura, Yasuyoshi;
- Bando, Yukari;
- Terakawa, Tomoaki;
- Harada, Kenichi;
- Takahashi, Satoru;
- Nakano, Yuzo;
- Fujisawa, Masato
Publication type:
Article
Efficacy and safety of pembrolizumab and axitinib as first‐line treatment for patients with advanced renal cell carcinoma: Real‐world experience in Japan.
Published in:
International Journal of Urology, 2023, v. 30, n. 9, p. 772, doi. 10.1111/iju.15230
By:
- Harada, Ken‐ichi;
- Sato, Ryo;
- Bando, Yukari;
- Sano, Asuka;
- Matsushita, Yuto;
- Tamura, Keita;
- Terakawa, Tomoaki;
- Furukawa, Junya;
- Fujimoto, Naohiro;
- Fujisawa, Masato;
- Miyake, Hideaki
Publication type:
Article
Editorial Comment on "Impact of cytoreductive nephrectomy prior to combination therapy of ipilimumab plus nivolumab in metastatic renal cell carcinoma".
Published in:
International Journal of Urology, 2023, v. 30, n. 9, p. 752, doi. 10.1111/iju.15210
By:
- Teishima, Jun
Publication type:
Article
Real‐world effectiveness of nivolumab and subsequent therapy in Japanese patients with metastatic renal cell carcinoma (POST‐NIVO study): 36‐month follow‐up results of a clinical chart review.
Published in:
International Journal of Urology, 2023, v. 30, n. 9, p. 762, doi. 10.1111/iju.15206
By:
- Yonese, Junji;
- Hinata, Nobuyuki;
- Masui, Satoru;
- Nakai, Yasutomo;
- Shirotake, Suguru;
- Takeuchi, Ario;
- Inamoto, Teruo;
- Nozawa, Masahiro;
- Ueda, Kosuke;
- Etsunaga, Toru;
- Osawa, Takahiro;
- Uemura, Motohide;
- Kimura, Go;
- Numakura, Kazuyuki;
- Yamana, Kazutoshi;
- Miyake, Hideaki;
- Fukasawa, Satoshi;
- Morishima, Naoto;
- Ito, Hiroaki;
- Uemura, Hirotsugu
Publication type:
Article
Hemoglobin and neutrophil levels stratified according to International Metastatic Renal Cell Carcinoma Database Consortium risk predict the effectiveness of ipilimumab plus nivolumab in patients with advanced metastatic renal cell carcinoma.
Published in:
International Journal of Urology, 2023, v. 30, n. 9, p. 754, doi. 10.1111/iju.15198
By:
- Tomiyama, Nami;
- Tasaki, Yoshihiko;
- Hamamoto, Shuzo;
- Sugiyama, Yosuke;
- Naiki, Taku;
- Etani, Toshiki;
- Taguchi, Kazumi;
- Matsuyama, Nayuka;
- Sue, Yasuhito;
- Mimura, Yoshihisa;
- Odagiri, Kunihiro;
- Noda, Yusuke;
- Aoki, Maria;
- Moritoki, Yoshinobu;
- Nozaki, Satoshi;
- Kurokawa, Satoshi;
- Okada, Atsushi;
- Kawai, Noriyasu;
- Furukawa‐Hibi, Yoko;
- Yasui, Takahiro
Publication type:
Article
Impact of cytoreductive nephrectomy prior to combination therapy of ipilimumab plus nivolumab in metastatic renal cell carcinoma.
Published in:
International Journal of Urology, 2023, v. 30, n. 9, p. 746, doi. 10.1111/iju.15193
By:
- Hara, Takuto;
- Furukawa, Junya;
- Shiraishi, Yusuke;
- Okamura, Yasuyoshi;
- Bando, Yukari;
- Terakawa, Tomoaki;
- Harada, Kenichi;
- Nakano, Yuzo;
- Fujisawa, Masato
Publication type:
Article
Editorial Comment to Significance of second progression‐free survival in patients with advanced urothelial cancer who received platinum‐based combination chemotherapy followed by pembrolizumab.
Published in:
International Journal of Urology, 2023, v. 30, n. 9, p. 736, doi. 10.1111/iju.15169
By:
- Matsumoto, Hiroaki
Publication type:
Article
Differential impact of proton pump inhibitor on survival outcomes of patients with advanced urothelial carcinoma treated with chemotherapy versus pembrolizumab.
Published in:
International Journal of Urology, 2023, v. 30, n. 9, p. 738, doi. 10.1111/iju.15151
By:
- Tomisaki, Ikko;
- Harada, Mirii;
- Sakano, Shigeru;
- Terado, Michikazu;
- Hamasuna, Ryoichi;
- Harada, Shuji;
- Matsumoto, Hiroomi;
- Akasaka, Soichiro;
- Nagata, Yujiro;
- Minato, Akinori;
- Harada, Ken‐ichi;
- Fujimoto, Naohiro
Publication type:
Article
Editorial Comment on Clinical outcomes of nivolumab plus ipilimumab in patients with metastatic non‐clear cell renal cell carcinoma: Real‐world data from a Japanese multicenter retrospective study.
Published in:
International Journal of Urology, 2023, v. 30, n. 9, p. 721, doi. 10.1111/iju.15146
By:
- Yuasa, Takeshi
Publication type:
Article
Utility of prognostic prediction by early assessment of response to combined treatment with nivolumab plus ipilimumab in patients with treatment‐naïve metastatic renal cell carcinoma.
Published in:
International Journal of Urology, 2023, v. 30, n. 9, p. 798, doi. 10.1111/iju.15144
By:
- Harada, Ken‐ichi;
- Miyake, Hideaki;
- Furukawa, Junya;
- Fujimoto, Naohiro;
- Fujisawa, Masato
Publication type:
Article
Significance of second progression‐free survival in patients with advanced urothelial cancer who received platinum‐based combination chemotherapy followed by pembrolizumab.
Published in:
International Journal of Urology, 2023, v. 30, n. 9, p. 730, doi. 10.1111/iju.15133
By:
- Sato, Ryo;
- Inamoto, Teruo;
- Matsushita, Yuto;
- Takemura, Ayana;
- Uchimoto, Taizo;
- Sano, Asuka;
- Tanaka, Hiroki;
- Ishikawa, Gaku;
- Watanabe, Kyohei;
- Watanabe, Hiromitsu;
- Tamura, Keita;
- Motoyama, Daisuke;
- Sugiyama, Takayuki;
- Otsuka, Atsushi;
- Harada, Ken‐ichi;
- Azuma, Haruhito;
- Miyake, Hideaki
Publication type:
Article
A comparative study on nivolumab and axitinib as secondary treatment in patients with metastatic renal cell carcinoma: A multi‐institutional retrospective study in Japan.
Published in:
International Journal of Urology, 2023, v. 30, n. 9, p. 723, doi. 10.1111/iju.15130
By:
- Kato, Taigo;
- Yumiba, Satoru;
- Nakata, Wataru;
- Nakano, Kosuke;
- Nagahara, Akira;
- Matsuzaki, Kyosuke;
- Hayashi, Yujiro;
- Hatano, Koji;
- Kawashima, Atsunari;
- Takao, Tetsuya;
- Nishimura, Kensaku;
- Nakai, Yasutomo;
- Nakayama, Masashi;
- Nishimura, Kazuo;
- Takada, Shingo;
- Tsujihata, Masao;
- Uemura, Motohide;
- Nonomura, Norio;
- Imamura, Ryoichi
Publication type:
Article
Clinical outcomes of nivolumab plus ipilimumab in patients with metastatic non‐clear cell renal cell carcinoma: Real‐world data from a Japanese multicenter retrospective study.
Published in:
International Journal of Urology, 2023, v. 30, n. 9, p. 714, doi. 10.1111/iju.15128
By:
- Izumi, Keita;
- Inoue, Masaharu;
- Washino, Satoshi;
- Shirotake, Suguru;
- Kagawa, Makoto;
- Takeshita, Hideki;
- Miura, Yuji;
- Hyodo, Yoji;
- Oyama, Masafumi;
- Kawakami, Satoru;
- Miyagawa, Tomoaki;
- Saito, Kazutaka;
- Kageyama, Yukio
Publication type:
Article
Editorial comment to real‐world outcomes of pembrolizumab for platinum refractory advanced urothelial carcinoma: Efficacy, safety, and evidence for trial‐unfit patients.
Published in:
International Journal of Urology, 2023, v. 30, n. 9, p. 704, doi. 10.1111/iju.15113
By:
- Goto, Yusuke
Publication type:
Article
Optimization of first‐line systemic therapy in patients with advanced clear cell renal cell carcinoma.
Published in:
International Journal of Urology, 2023, v. 30, n. 9, p. 705, doi. 10.1111/iju.15103
By:
- Takagi, Toshio
Publication type:
Article
Real‐world outcomes of pembrolizumab for platinum‐refractory advanced urothelial carcinoma: Efficacy, safety, and evidence for trial‐unfit patients.
Published in:
International Journal of Urology, 2023, v. 30, n. 9, p. 696, doi. 10.1111/iju.15101
By:
- Ito, Katsuhiro;
- Kita, Yuki;
- Kobayashi, Takashi
Publication type:
Article